False
April 20, 2026
Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T
4 min read
April 16, 2026
The company says the acquisition will strengthen downstream antibody manufacturing and help biopharma customers scale more efficiently.
April 7, 2026
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
1 min read
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
March 31, 2026
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration
1 min read
By Audrey Greenberg
March 30, 2026
From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter.
5 min read
March 25, 2026
Two iPSC-derived cell therapies receive time-limited authorization following early clinical trials
2 min read
By Julia Cipriano
March 19, 2026
Preclinical results and AI integration support progress toward regulatory submission
1 min read
By Priya Baraniak
March 17, 2026
How 2025 marked biology’s shift toward engineering discipline
3 min read
False